Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Vaccine Immunol ; 18(1): 35-42, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21047998

ABSTRACT

Although high measles, mumps, and rubella (MMR) vaccination coverage has been successful in dramatically reducing mumps disease in the United States, mumps (re)infections occasionally occur in individuals who have been either previously vaccinated or naturally infected. Standard diagnostics that detect virus or virus-specific antibody are dependable for confirming primary mumps infection in immunologically naïve persons, but these methods perform inconsistently for individuals with prior immune exposure. We hypothesized that detection of activated mumps-specific antibody-secreting B cells (ASCs) by enzyme-linked immunospot (ELISPOT) assay could be used as a more reliable diagnostic. To test this, a time course of virus-specific ASC responses was measured by ELISPOT assay following MMR vaccination of 16 previously vaccinated or naturally exposed adult volunteers. Mumps-specific ASCs were detectable in 68% of these individuals at some point during the first 3 weeks following revaccination. In addition, mumps-specific ASCs were detected in 7/7 previously vaccinated individuals who recently had been infected as part of a confirmed mumps outbreak. These data suggest that ELISPOT detection of mumps-specific ASCs has the potential for use as an alternative method of diagnosis when suspect cases cannot be confirmed by detection of IgM or virus. In addition, it was determined that mumps-specific memory B cells are detected at a much lower frequency than measles- or rubella-specific cells, suggesting that mumps infection may not generate robust B-cell memory.


Subject(s)
Antibodies, Viral/blood , B-Lymphocytes/immunology , Enzyme-Linked Immunospot Assay/methods , Measles-Mumps-Rubella Vaccine/administration & dosage , Mumps virus/immunology , Mumps/diagnosis , Adult , Antibodies, Viral/immunology , Antibody-Producing Cells/immunology , Humans , Immunologic Memory/immunology , Measles/immunology , Measles/prevention & control , Measles virus/immunology , Measles-Mumps-Rubella Vaccine/immunology , Middle Aged , Mumps/immunology , Mumps/prevention & control , Rubella/immunology , Rubella/prevention & control , Rubella virus/immunology , United States , Vaccination
2.
J Wildl Dis ; 45(2): 375-87, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19395747

ABSTRACT

In this study, we review annual rabies data from Massachusetts from 1985 to 2006, spanning the introduction of raccoon strain rabies in 1992. Of 52,034 animals tested, 9.7% (5,049/52,034) were rabid, representing 26 of over 67 species submitted. Bats were the most common rabid animals prior to 1992 (50 of 52), but raccoons (Procyon lotor) became the most common rabies-positive species upon arrival of raccoon strain rabies virus (38.2%, 2,728 of 7,138 tested), followed by striped skunks (Mephitis mephitis, 34.4%, 1,489 of 4,332), bats (5.3%, 427 of 8,053), foxes (red fox, Vulpes vulpes, and gray fox, Urocyon cinereoargenteus, 16.3%, 135 of 827), cats (0.8%, 136 of 18,050), and woodchucks (Marmota monax, 5.7%, 82 of 1,446). Cats were the most frequently tested animal (34.7%). Raccoon strain rabies spread from two foci of introduction with an initial epizootic phase of 4 yr, by which time most of the state was affected. In 1992, there was a transition from enzootic bat rabies, with little spillover to other animals, to terrestrial rabies associated with raccoon strain virus. Although raccoons were most affected by the raccoon strain virus, there was spillover to other species, particularly to skunks. The eastern United States raccoon rabies epizootic led to a marked increase in submissions for rabies testing and the number of positive animals detected; however, bat rabies cases remained at their previous levels. Wild animal rabies presents a significant threat to humans and domestic/companion animals and increased costs related to increased demand for rabies testing, postexposure prophylaxis as well as euthanasia of valuable domestic animals.


Subject(s)
Animals, Domestic/virology , Animals, Wild/virology , Antibodies, Viral/blood , Rabies virus/immunology , Rabies/veterinary , Animals , Cat Diseases/epidemiology , Cat Diseases/transmission , Cats , Chiroptera/virology , Disease Reservoirs/veterinary , Disease Reservoirs/virology , Dog Diseases/epidemiology , Dog Diseases/transmission , Dogs , Female , Fluorescent Antibody Technique, Direct/veterinary , Foxes/virology , Male , Massachusetts/epidemiology , Mephitidae/virology , Rabies/epidemiology , Rabies/transmission , Raccoons/virology , Seasons , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...